Biomedical subjects

Er-Xin Yu

Publications and source records attributed to Er-Xin Yu.

4 recordsLinked to original sources

PubMed2003

[Restoring the harmony and order of the body: treatment of cancer patients according to syndrome differentiation].

By reviewing the clinical work of the past 40 years and combining with the theories of traditional Chinese medicine, the author proposed that the spleen plays a key role in treating liver cancer according to syndrome differentiation. Based on the clinical and experimental research work, the author advanced a theory that the goal of the treatment of cancer according to syndrome differentiation is to restore the harmony and order of the body. Further research into this theory will be conducive to establishing a new theoretical system of integrative medicine on cancer treatment.

Humans↗

PubMed2003

Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma.

AIM: To investigate the efficacy of transcatheter arterial chemoembolization (TACE) combined with radiotherapy for unresectable large hepatocellular carcinoma (HCC). METHODS: From June 1994 to June 1999, a total of 76 patients with large unresectable HCC were treated with TACE followed by external-beam irradiation. 89 patients with large HCC, who underwent TACE alone during the same period, served as the control group. Clinical features, therapeutic modalities, acute effects and survival rates were analyzed and compared between TACE plus irradiation group and TACE alone group. A multivariate analysis of nine clinical variables and one treatment variable (irradiation) was performed by the Cox proportional hazards model. RESULTS: The clinical features and therapeutic modalities except irradiation between the two groups were comparable (P>0.05). The objective response rate (RR) in TACE plus irradiation group was higher than that in TACE alone group (47.4 % vs 28.1 %, P<0.05). The overall survival rates in TACE plus irradiation group (64.0 %, 28.6 %, and 19.3 % at 1, 3, 5 years, respectively) were significantly higher than those in TACE alone group (39.9 %, 9.5 %, and 7.2 %, respectively, P=0.0001). Cox proportional hazards model analysis showed that tumor extension and Child grade were significant and were independent negative predictors of survival, while irradiation was an independent positive predictor of survival. CONCLUSION: TACE combined with radiotherapy is more effective than TACE alone, and is a promising treatment for unresectable large HCC.

Carcinoma, Hepatocellular↗

PubMedDate not supplied

The long-term efficacy of combined chemoembolization and local irradiation in the treatment of patients with large hepatocellular carcinoma.

BACKGROUND/AIMS: To investigate the effects and toxicity of combined transcatheter arterial chemoembolization and local radiotherapy for patients with unresectable hepatocellular carcinoma. METHODOLOGY: From June 1994 to June 1999, 28 patients with unresectable hepatocellular carcinoma (the largest dimension of tumor ranged from 3 to 10 cm) were treated with transcatheter arterial chemoembolization followed by local irradiation. Response was assessed by computed tomography scan and ultrasound, together with serum alpha-fetoprotein level in cases with increased baseline values. Complications associated with treatment were monitored. Cumulative survival was determined by Kaplan-Meier method from the first day of treatment. RESULTS: An objective response (reduction of tumor area greater than 50%) was achieved in 57.0% of the cases. In 63.0% of the cases with increased alpha-fetoprotein values, alpha-fetoprotein level underwent a marked reduction (more than 50%). The cumulative survival rates at 1, 3, and 5 years were 81.9%, 42.4%, and 21.2%, respectively (median survival, 31 months, 95% CI: 27.8-34.2 months). The combination therapy was generally well tolerated. CONCLUSIONS: The results suggest that combined transcatheter arterial chemoembolization with local radiotherapy is an effective and safe treatment for unresectable hepatocellular carcinoma. Further study is required to compare the therapeutic efficacy of this regimen to transcatheter arterial chemoembolization or radiotherapy alone.

Adult↗

PubMedDate not supplied

Large primary liver cancer treated by chemoembolization combined with radiotherapy successfully.

For unresectable primary liver cancer, transcatheter arterial chemoembolization is the most effective method in reducing the size of tumor and become the most popular forms in Asia, but, it is not a curative approach and additional therapy is needed to kill the residual tumor cells. In this paper, we report a case in which a patient with a single very large liver cancer has been successfully treated by chemoembolization combined with radiotherapy. The results suggest that this is a very promising therapeutic approach for single large primary liver cancer.

Antibiotics, Antineoplastic↗